PLACENTAL TOXICOLOGY
PLACENTAL TOXICOLOGY
批准号:
3250063
负责人:
Richard Kermit Miller
金额:
$28.85万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1982
资助国家:
美国
项目状态:
已结题
起止时间:
1982-12-02 至 1992-11-30
关键词:
atomic absorption spectrometry binding proteins biological models biomarker cadmium calcium electron microscopy embryo /fetus toxicology environmental adaptation environmental toxicology gestational age high performance liquid chromatography hormone biosynthesis human pregnant subject human tissue magnetic resonance imaging metal metabolism metal poisoning metallothionein mixed tissue /cell culture model design /development nuclear magnetic resonance spectroscopy organ culture physiology placenta placental transfer psychobiology radioimmunoassay respiratory gas analyzer respiratory gas level respiratory gas transport selenium tobacco abuse toxicant interaction toxin metabolism trophoblast zinc
中文摘要
胎盘可能是特定毒性作用的部位,损害
胚胎从出生到分娩的生长和存活,例如。
镉可导致啮齿动物胎盘坏死和胎儿死亡
人胎盘在灌流条件下的坏死。在过去
两年来,我们已经将人类胎盘的灌流时间延长到24小时
并开发了滋养层细胞和人类的三维培养
子宫内膜培养模式,从分离的细胞发展成腺体
间质被上皮所覆盖。利用灌流的人胎盘
都证明了锌可以保护人体免受
人体胎盘中的镉。此外,镉的初始作用
似乎是蛋白质合成而不是ATP,因为31P核磁共振/核磁共振
光谱分析显示HPL和hCG对ATP无明显影响
减少了。进一步的研究证实了对三磷酸腺苷的持续监测
证明人类胎盘有巨大的糖酵解
能力;然而,一旦耗尽-ATP水平确实会下降;然而,在
如果发生复氧,ATP的恢复是迅速和持久的。
在正常情况下,ATP水平在10小时内保持不变
灌流条件(研究的最长时间)。更多研究表明
证明人类胎盘(包括早期和晚期胎盘)可以代谢
类维甲酸,特别是异维甲酸(阿卡托品)为维甲酸。是这样的
人类胎盘的新陈代谢可能是该物种的部分原因
啮齿类动物与人类在致畸性方面的差异
这些特工。此外,还证明了肠道病毒不能穿透。
通过人类胎盘,即使在暴露15小时后,当病毒
在母体灌流液和胎盘样本中发现。具体目标
这一建议的主要内容是:1.确定镉(Cd)的关系
毒性及其修饰剂(锌、硒、钙)
已知胎盘功能和形态,2.确定早期
滋养层细胞及其与人子宫内膜的相互作用
(附着/侵入(“植入”)对镉和RU486有反应,3.
由于镉诱导金属硫蛋白(MT),确定其调节
MT(I/II)的诱导及其与镉保护的关系
毒性,以及4.研究怀孕的不吸烟者和吸烟者的胎盘(>;30
香烟/天),然后确定重度吸烟者是否
对体外急性胎盘毒性有保护作用。
英文摘要
The placenta can be a site for specific toxic action compromising the
growth and survival of the conceptus from birth until delivery, e.g,.
cadmium can produce placental necrosis and fetal death in rodents and
necrosis under perfusion conditions in the human placenta. During the past
two years, we have extended the perfusion of human placentae to 24 hours
and developed a 3-dimensional culture of trophoblast and a human
endometrial culture model, which develops from isolated cells into glands
and stroma covered by epithelium. Utilizing the perfused human placenta we
have documented that zinc can protect against acute toxic effects of
cadmium in the human placenta. In addition, the initial actions of cadmium
appear to be on protein synthesis rather than ATP, since 31p NMR/MRI
spectroscopy demonstrated no effect on ATP while hPL and hCG were
decreased. Further studies demonstrated continuous monitoring of ATP
demonstrated that the human placenta has the tremendous glycolytic
capacity; however, once exhausted - ATP levels do fall; however, at that
point if reoxygenation occurs, recovery of ATP is rapid and persistent.
ATP levels have been found constant for period of 10 hours under normal
perfusion conditions (longest period studied). Additional studies have
demonstrated that the human placenta (both early and term) can metabolize
retinoids, in particular isotretinoin (Accutane) to tretinoin. Such
metabolism by the human placenta may partially account for the species
differences between rodents and human concerning the teratogenicity of
these agents. Also it was demonstrated that enteroviruses do not penetrate
through he human term placenta even after 15 hours of exposure, when virus
is found in maternal perfusate and placental specimens. The specific aims
of this proposal are: 1. Determine the relationship between cadmium (Cd)
toxicity and modifiers of that toxicity (zinc, selenium and calcium) on
known placental function and morphology, 2. Determine if the early
trophoblast and its interaction with the human endometrium
(Attachment/Invasion ("implantation") is responsive to Cd and Ru486, 3.
Since Cd induces metallothionein (MT), determine the regulation of
induction of MT(I/II) and its relationship to protection against Cd
toxicity, and 4. Study placentae from pregnant nonsmokers and smokers (>30
cigarettes/day) using perfusion and then determine if heavy smokers are
protected from the acute placental toxicity in vitro.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Human Placental Morphology, Function, and Pathology: Relationship to Environmental Exposures and Newborn and Child Health
-
批准号:10457073
-
项目类别:
-
资助金额:$3.02万
-
财政年份:2018
-
负责人:Richard Kermit Miller
-
依托单位:
Nanoparticles in the Human Placenta:Toxicokinetics
-
批准号:7885351
-
项目类别:
-
资助金额:$7.57万
-
财政年份:2009
-
负责人:Richard Kermit Miller
-
依托单位:
Nanoparticles in the Human Placenta:Toxicokinetics
-
批准号:7660838
-
项目类别:
-
资助金额:$7.7万
-
财政年份:2009
-
负责人:Richard Kermit Miller
-
依托单位:
Placenta: Ethanol and HIV
-
批准号:6753449
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2002
-
负责人:Richard Kermit Miller
-
依托单位:
Placenta: Ethanol and HIV
-
批准号:6555960
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2002
-
负责人:Richard Kermit Miller
-
依托单位:
Placenta: Ethanol and HIV
-
批准号:6651630
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2002
-
负责人:Richard Kermit Miller
-
依托单位:
PLACENTA--IMPLANTATION TO DELIVERY
-
批准号:6225834
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2000
-
负责人:Richard Kermit Miller
-
依托单位:
REGULATION OF PLACENTAL FUNCTION
-
批准号:2207922
-
项目类别:
-
资助金额:$1.2万
-
财政年份:1996
-
负责人:Richard Kermit Miller
-
依托单位:
PLACENTA-ANTIHIV THERAPY
-
批准号:2886736
-
项目类别:
-
资助金额:$41.92万
-
财政年份:1991
-
负责人:Richard Kermit Miller
-
依托单位:
PLACENTA--ANTI-HIV THERAPY
-
批准号:3147323
-
项目类别:
-
资助金额:$23.3万
-
财政年份:1991
-
负责人:Richard Kermit Miller
-
依托单位:
PLACENTA--ANTI-HIV THERAPY
-
批准号:3147324
-
项目类别:
-
资助金额:$25.33万
-
财政年份:1991
-
负责人:Richard Kermit Miller
-
依托单位:
PLACENTA ANTIHIV THERAPY
-
批准号:6042304
-
项目类别:
-
资助金额:$1.13万
-
财政年份:1991
-
负责人:Richard Kermit Miller
-
依托单位:
PLACENTA--ANTIHIV THERAPY
-
批准号:2067191
-
项目类别:
-
资助金额:$26.36万
-
财政年份:1991
-
负责人:Richard Kermit Miller
-
依托单位:
PLACENTA-ANTIHIV THERAPY
-
批准号:2672109
-
项目类别:
-
资助金额:$31.4万
-
财政年份:1991
-
负责人:Richard Kermit Miller
-
依托单位:
PLACENTA-ANTIHIV THERAPY
-
批准号:2442503
-
项目类别:
-
资助金额:$30.56万
-
财政年份:1991
-
负责人:Richard Kermit Miller
-
依托单位:
PLACENTA--ANTI-HIV THERAPY
-
批准号:3147325
-
项目类别:
-
资助金额:$25.35万
-
财政年份:1991
-
负责人:Richard Kermit Miller
-
依托单位:
PLACENTA-ANTIHIV THERAPY
-
批准号:2067192
-
项目类别:
-
资助金额:$29.75万
-
财政年份:1991
-
负责人:Richard Kermit Miller
-
依托单位:
PLACENTAL TOXICOLOGY
-
批准号:3250062
-
项目类别:
-
资助金额:$19.95万
-
财政年份:1982
-
负责人:Richard Kermit Miller
-
依托单位:
PLACENTAL TOXICOLOGY
-
批准号:3250068
-
项目类别:
-
资助金额:$17.35万
-
财政年份:1982
-
负责人:Richard Kermit Miller
-
依托单位:
PLACENTAL TOXICOLOGY
-
批准号:3250070
-
项目类别:
-
资助金额:$20.39万
-
财政年份:1982
-
负责人:Richard Kermit Miller
-
依托单位:
海外基金